COVID-19: WHO recommends Regeneron antibody therapy for high-risk & seronegative patients

Price and production problems should be addressed at the earliest, the health agency says  

Medicines Pool Swirls

Drug companies are slowly joining the UN effort to offer life-saving patented medicines to poor countries but the terms are sometimes restrictive

‘Manipulate market, lower drug prices’

In times of rising costs of healthcare compounded by shortage of funds, UNITAID, a UN organisation, was set up in 2006 to improve access to life-…

Obama takes first dip

The US becomes the first to join a global patents pool to make AIDS drugs cheaper but health workers are sceptical of the initiative